Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications
View abstract on PubMed
Summary
This summary is machine-generated.Pediatric low-grade gliomas (PLGGs) are common childhood brain tumors. Understanding their molecular pathways, like RAS/MAPK signaling, and tumor microenvironment is key for better treatment strategies and reducing long-term side effects.
Area Of Science
- Neuro-oncology
- Pediatric oncology
- Molecular biology
Background
- Pediatric low-grade gliomas (PLGGs) are the most common CNS tumors in children and adolescents.
- Despite high survival rates, long-term morbidity from disease and therapy is a significant concern.
- Recent research highlights the critical role of RAS/MAPK and mTOR signaling pathways in PLGG development.
Purpose Of The Study
- To review the current understanding of cellular mechanisms and clinical factors influencing PLGG progression.
- To explore the impact of molecular pathways, such as RAS/MAPK signaling, on tumor behavior.
- To provide a foundation for improved patient stratification and multimodal treatment approaches.
Main Methods
- Review of recent molecular profiling and genetic landscape studies of PLGGs.
- Analysis of in vitro and in vivo research on PLGG formation and growth.
- Synthesis of findings on oncogene-induced senescence and tumor microenvironment interactions.
Main Results
- RAS/MAPK and mTOR signaling pathways are frequently upregulated in PLGG tumorigenesis.
- RAS/MAPK-driven oncogene-induced senescence influences tumor progression patterns.
- PLGG growth is strongly dependent on the tumor microenvironment.
Conclusions
- A comprehensive understanding of PLGG biology is essential for effective management.
- Targeting molecular pathways and the tumor microenvironment offers potential for novel therapies.
- Advanced stratification based on molecular and clinical factors can optimize multimodal treatment strategies.

